ATLASEstrella Immunopharma (ESLA) earnings date: expected November 5–11
Estrella Immunopharma (ESLA) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around November 5–11. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ESLA
| Last price | $0.47 (-27.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.4% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Estrella Immunopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around November 5–11 (estimate). One email the day before, with ATLAS’s read on Estrella Immunopharma. You can switch it off at any time.
Alert me before ESLA reportsFree to start. Creating an account takes under a minute.
Notify me when Estrella Immunopharma reports
Track ESLA free Add Estrella Immunopharma to a free ATLAS watchlist and see its next report date in one place.
ESLA earnings at a glance
| Next report | Not announced · expected around November 5–11 (ATLAS estimate) |
|---|---|
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +50.4% |
| Average move around a report | ±4.0% (last 5) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Estrella Immunopharma’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Estrella Immunopharma earnings history: last 5 reports
Estrella Immunopharma last reported on Aug 13, 2026: EPS of -$0.05 against an estimate of -$0.09 (+44.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.09 | -$0.05 | +44.4% | Beat | -2.3% |
| May 18, 2026 | -$0.19 | -$0.05 | +73.7% | Beat | +2.7% |
| Mar 18, 2026 | -$0.07 | -$0.01 | +85.7% | Beat | -0.9% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | +8.1% |
| Nov 18, 2025 | $0.25 | $0.33 | +32.0% | Beat | -5.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ESLA
See the fair value, the probability range and the earnings history of Estrella Immunopharma on its ATLAS page.
Estrella Immunopharma (ESLA) stock analysisPlans from €3.99 a month.
Estrella Immunopharma earnings: frequently asked questions
When is Estrella Immunopharma (ESLA) next earnings date?
Estrella Immunopharma has not announced its next report. Its last 4 reports came Aug 13, 2026, May 18, 2026, Mar 18, 2026, Nov 18, 2025, so ATLAS estimates the next one around November 5–11. This is an estimate based on that pattern, not a confirmed date.
How often does ESLA beat earnings estimates?
Of its last 5 reports with a recorded result, Estrella Immunopharma beat the EPS estimate 5 times; the average surprise was +50.4%. Past results do not predict the next one.
How much does ESLA move around earnings?
Over its last 5 reports the stock moved an average of 4.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Estrella Immunopharma beat earnings estimates last quarter?
Estrella Immunopharma last reported on Aug 13, 2026: EPS of -$0.05 against an estimate of -$0.09 (+44.4% surprise), a beat.
How much does ESLA usually move in a day?
On a normal trading day the ATLAS model puts ESLA’s one-day range at about ±10.4%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer